SCHEMBL6368226

SCHEMBL6368226

NCCCCNc1cccc2c1C(=O)c1cccc(NCCCCN)c1C2=O

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NSD2 O96028 2/20 0.61
▸ FGB P02675 1/20 0.61
▸ MMP14 P50281 1/20 0.61
▸ MEN1 O00255 5/20 0.56
▸ KMT2A Q03164 5/20 0.56
▸ MAPT P10636 4/20 0.56
▸ SMN1; SMN2 Q16637 3/20 0.56
▸ POLB P06746 3/20 0.56
▸ EGFR P00533 2/20 0.56
▸ MAPK1 P28482 2/20 0.56
▸ L3MBTL1 Q9Y468 2/20 0.56
▸ ALDH1A1 P00352 2/20 0.56
▸ HTT P42858 2/20 0.56
▸ BLM P54132 2/20 0.56
▸ LMNA P02545 1/20 0.56
▸ RAD52 P43351 1/20 0.56
▸ RECQL P46063 1/20 0.56
▸ NPSR1 Q6W5P4 1/20 0.56
▸ TERT O14746 2/20 0.50
▸ TOP2B Q02880 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6372356 0.98 NSD2 (0.60) NSD2FGBMMP14MEN1KMT2A
SCHEMBL8602072 0.95 MAPT (0.63) NSD2FGBMMP14MEN1KMT2A
SCHEMBL20334284 0.95 NSD2 (0.63) NSD2FGBMMP14MEN1KMT2A
SCHEMBL32667983 0.94 MAPT (0.61) NSD2FGBMMP14MEN1KMT2A
Hydrochloric Acid SCHEMBL8603274 0.94 MAPT (0.61) NSD2FGBMMP14MEN1KMT2A
SCHEMBL8601416 0.94 MAPT (0.61) NSD2FGBMMP14MEN1KMT2A
SCHEMBL6366937 0.94 TERT (0.57) NSD2FGBMMP14MEN1KMT2A
SCHEMBL20333883 0.94 TERT (0.57) NSD2FGBMMP14MEN1KMT2A
Hydrochloric Acid SCHEMBL8604068 0.93 MAPT (0.60) NSD2FGBMMP14MEN1KMT2A
SCHEMBL109325 0.90 MEN1 (0.64) NSD2FGBMMP14MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050009924-A1 Synthesis and pharmaceuticals of novel bis-substituted anthraquinone derivatives HUANG HSU-SHAN (TW) 2005-01-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050009924-A1 Synthesis and pharmaceuticals of novel bis-substituted anthraquinone derivatives NFE2L2, NR2F2, TFAM NSD2 2666/4885FGB 3192/4885MMP14 2848/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback